中国科学院机构知识库网格
Chinese Academy of Sciences Institutional Repositories Grid
Multicenter real-world experiences of PARPi rechallenge in patients with ovarian cancer in China

文献类型:期刊论文

作者Li, Jin2; Shao, Feng3; Zhao, Lingjun4; Zheng, Fei5; Zhu, Hua6; Li, Enchun7; Zhou, Wei8; Yao, Guorong1; Liu, Jie9; Zheng, Jianxiao10
刊名INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER
出版日期2023-11-01
卷号33
ISSN号1048-891X
DOI10.1136/ijgc-2023-IGCS.104
WOS研究方向Oncology ; Obstetrics & Gynecology
语种英语
WOS记录号WOS:001262421600213
出版者BMJ PUBLISHING GROUP
源URL[http://ir.hfcas.ac.cn:8080/handle/334002/135893]  
专题中国科学院合肥物质科学研究院
作者单位1.Huzhou Cent Hosp, Dept Integrated Chinese & Western Med, Huzhou, Peoples R China
2.Fudan Univ, Dept Gynecol Oncol, Shanghai Canc Ctr, Shanghai, Peoples R China
3.Univ Chinese Acad Sci, Zhejiang Canc Hosp, Gynecol Surg Dept, Canc Hosp, Hangzhou, Peoples R China
4.Ningbo Women & Childrens Hosp, Dept Gynecol, Ningbo, Peoples R China
5.Ningbo 2 Hosp, Dept Gynecol, Ningbo, Peoples R China
6.Wenzhou Med Univ, Dept Gynecol, Affiliated Hosp 1, Wenzhou, Peoples R China
7.Zhejiang Univ, Dept Gynecol, Womens Hosp, Sch Med, Hangzhou, Peoples R China
8.Taizhou Hosp Zhejiang Prov, Dept Gynecol, Taizhou, Peoples R China
9.Jinhua Peoples Hosp, Dept Gynecol, Jinhua, Peoples R China
10.Yueqing Peoples Hosp, Dept Integrated Chinese & Western Med, Wenzhou, Peoples R China
推荐引用方式
GB/T 7714
Li, Jin,Shao, Feng,Zhao, Lingjun,et al. Multicenter real-world experiences of PARPi rechallenge in patients with ovarian cancer in China[J]. INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER,2023,33.
APA Li, Jin.,Shao, Feng.,Zhao, Lingjun.,Zheng, Fei.,Zhu, Hua.,...&Wu, Xiaohua.(2023).Multicenter real-world experiences of PARPi rechallenge in patients with ovarian cancer in China.INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER,33.
MLA Li, Jin,et al."Multicenter real-world experiences of PARPi rechallenge in patients with ovarian cancer in China".INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER 33(2023).

入库方式: OAI收割

来源:合肥物质科学研究院

浏览0
下载0
收藏0
其他版本

除非特别说明,本系统中所有内容都受版权保护,并保留所有权利。